Lobbying

Illinois Health & Hospital Association's latest lobbying report covers Q2 2026, at $110K. The four quarters Q4 2025–Q3 2026 total $360K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medicare/Medicaid.

Illinois Health & Hospital Association

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$360K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Illinois Health & Hospital Association lobbying by quarter
Illinois Health & Hospital Association lobbying by quarter
QuarterAmountReports
Q4 2022$200K1
Q1 2023$170K1
Q2 2023$100K1
Q3 2023$60K1
Q4 2023$70K1
Q1 2024$90K1
Q2 2024$110K1
Q3 2024$70K1
Q4 2024$80K1
Q1 2025$90K1
Q2 2025$140K1
Q3 2025$190K1
Q4 2025$160K1
Q1 2026$90K1
Q2 2026$110K1
Q3 2026$00

By issue

  • Budget and appropriations$578.3K · 15 reports
  • Medicare and Medicaid$578.3K · 15 reports
  • Health issues$533.3K · 14 reports
  • Immigration$40K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Natl Institutes of Health (NIH)1 reports

Firms it paid

Firm
In-houseIllinois Health & Hospital Association$1.7M15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/15for Q2In-house$110K
04/16for Q1In-house$90K
01/16for Q4 2025In-house$160K
25/10/14for Q3 2025In-house$190K
25/07/17for Q3 2025In-houseUnder $5,000
25/07/17for Q3 2025In-houseUnder $5,000
25/07/16for Q2 2025In-house$140K
25/04/15for Q1 2025In-house$90K
25/01/16for Q4 2024In-house$80K
24/10/18for Q3 2024In-house$70K
24/07/18for Q2 2024In-house$110K
24/04/19for Q1 2024In-house$90K
24/01/19for Q4 2023In-house$70K
23/10/18for Q3 2023In-house$60K
23/07/17for Q2 2023In-house$100K
23/04/17for Q1 2023In-house$170K
23/01/19for Q4 2022In-house$200K